Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Landiolol bulk supplier for pharma manufacturers

Landiolol 300 mg , 600 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 300 mg , 600 mg

Reference Brands: Rapibloc (EU)

Category: Heart Disorder

Landiolol is a Heart Disorder product available as Injection in strengths 300 mg , 600 mg. It corresponds to the reference brand Rapibloc (EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Landiolol is an ultra-short-acting, highly β1-selective intravenous beta-adrenergic blocker used for the management of tachycardia and supraventricular arrhythmias such as atrial fibrillation and atrial flutter. It is marketed under brand names including Onoact and Rapiblyk and is administered as landiolol hydrochloride. Landiolol is specifically designed for rapid and precise heart rate control in acute and critical care settings where quick onset and easy titration are essential.

One of the key characteristics of landiolol is its extremely short elimination half-life of approximately 3 to 4 minutes, the shortest among available beta blockers. Its effect on heart rate begins almost immediately after administration, and heart rate typically returns to baseline within about 30 minutes after discontinuation. This allows clinicians to achieve predictable and reversible heart rate control. Due to its high β1-selectivity and pure S-enantiomer structure, landiolol has minimal effects on blood pressure and myocardial contractility compared to other beta blockers, resulting in a lower risk of hypotension.

Landiolol — third party manufacturing & bulk supply

Landiolol 300 mg , 600 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Landiolol listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Landiolol →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Landiolol hydrochloride is used for short-term control of ventricular rate in patients with supraventricular tachyarrhythmias, including atrial fibrillation and atrial flutter, especially in acute care and perioperative settings.

Landiolol hydrochloride is a synthetically manufactured beta-1 selective adrenergic receptor antagonist designed for intravenous administration.

The trade name of landiolol hydrochloride is Rapibloc.

Rapibloc was originally developed by Ono Pharmaceutical Co., Ltd., and is marketed in Europe by Amomed Pharma GmbH and its partners.

The generic name of Landiolol is landiolol hydrochloride.

The brand name of Landiolol is Rapibloc.

Landiolol hydrochloride injection is manufactured by GMP-approved pharmaceutical manufacturing facilities in Japan and the European Union, depending on the supplying company and market.

Related Products

Trandolapril

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Mavik (USA), Gopten (EU)

View Details
Tirofiban Hydrochloride

Strength:
2.5 mg/mL

Form: Injection

Reference Brands: Aggrastat (USA)

View Details
Selexipag

Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg

Form: Tablets / Injection

Reference Brands: Uptravi (USA/EU)

View Details
Edoxaban

Strength:
15 mg, 30 mg, 60 mg

Form: Tablets

Reference Brands: Savaysa (USA), Lixiana (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.